Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$142K Sell
7,639
-4,099
-35% -$81.7K 0.13% 295
2026
Q1
$221K Sell
11,738
-6,342
-35% -$119K 0.25% 91
2025
Q4
$283K Sell
18,080
-14,940
-45% -$222K 0.21% 163
2025
Q3
$438K Sell
33,020
-28,603
-46% -$370K 0.21% 174
2025
Q2
$766K Buy
61,623
+13,582
+28% +$171K 0.33% 77
2025
Q1
$731K Buy
48,041
+31,873
+197% +$477K 0.32% 75
2024
Q4
$236K Buy
+16,168
New +$253K 0.3% 90

Other funds holding NOV

Bayforest Capital's NOV Position: Q2 2026 in Review

Bayforest Capital reduced its NOV (NOV) stake by 35% in Q2 2026, selling an estimated $81.7K and leaving 7,639 shares worth $142K. The position accounts for 0.13% of the portfolio, ranked #295.

Bayforest Capital first reported a position in NOV in Q4 2024 and has held it in 7 quarters since. The position peaked at $766K in Q2 2025. 488 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • Bayforest Capital held 7,639 shares of NOV worth $142K as of Q2 2026.
  • Bayforest Capital sold 4,099 NOV shares in Q2 2026, an estimated $81.7K.
  • NOV made up 0.13% of Bayforest Capital's portfolio in Q2 2026, its #295 holding.
  • Bayforest Capital first reported a position in NOV in Q4 2024 and has held it in 7 quarters since.
  • Bayforest Capital's NOV position peaked at $766K in Q2 2025.
  • 488 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.